What are the differences between a chalazion and a stye (hordeolum) regarding cause, appearance, and treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Chalazion vs Stye: Key Differences

A stye (hordeolum) is a painful, rapidly developing infection at the eyelid margin with purulent discharge, while a chalazion is a painless, slowly developing nodule within the tarsal plate caused by meibomian gland obstruction.

Distinguishing Features

Stye (Internal Hordeolum)

  • Painful, erythematous nodule at the eyelid margin with acute inflammation and rapid onset 1, 2
  • Purulent discharge is commonly present 1
  • Associated with bacterial infection (typically staphylococcal) and bacterial blepharitis 1
  • Most cases resolve spontaneously within 5-14 days 1

Chalazion

  • Painless nodule within the tarsal plate with gradual onset 1, 2
  • Visible meibomian gland obstruction on eyelid eversion 1
  • Associated with meibomian gland dysfunction, posterior blepharitis, rosacea, or seborrheic dermatitis 1, 3
  • Can persist for months but may resolve spontaneously 1
  • If moderate to severe pain develops in a presumed chalazion, this requires immediate ophthalmologic evaluation as it may indicate secondary infection or atypical presentation 3

Treatment Approaches

Stye (Internal Hordeolum) Management

  • First-line: Warm compresses for 10-15 minutes, 3-4 times daily, combined with topical antibiotic drops or ointment 1
  • Gentle massage after warm compresses to promote spontaneous drainage 2
  • Institute regular eyelid hygiene measures 1
  • Note: Evidence for hordeolum treatment is notably weak, based primarily on expert consensus 1, 4, 5

Chalazion Management

  • Start with warm compresses for 5-10 minutes, 3-4 times daily, combined with eyelid hygiene 3, 2
  • Gentle massage after compresses to express the obstructed gland 3
  • Do not continue conservative management beyond 4-6 weeks without reassessment, as this delays diagnosis of potential malignancy 3, 2
  • For persistent chalazia after 4-6 weeks: intralesional triamcinolone acetonide injection (93.8% success rate vs 58.3% with conservative management alone) 3
  • Surgical excision if unresponsive to conservative and injection therapy 6

Critical Red Flags Requiring Biopsy

Always biopsy chalazia with these features to exclude sebaceous carcinoma:

  • Recurrence in the same location, especially in elderly patients 1, 3, 2
  • Marked asymmetry or resistance to standard therapy 3, 2
  • Atypical features: eyelid margin distortion, focal lash loss (madarosis), or ulceration 1, 3, 2
  • Unilateral chronic blepharitis unresponsive to therapy 1, 2
  • History of multiple excisions at the same site 1

Common Pitfalls to Avoid

  • Mistaking a painful chalazion for a typical presentation - moderate to severe pain warrants immediate ophthalmologic evaluation 3
  • Prolonged conservative management without reassessment - delays diagnosis of sebaceous carcinoma masquerading as chalazion 3, 2
  • Failing to address underlying conditions - treat bacterial blepharitis, meibomian gland dysfunction, rosacea, or seborrheic dermatitis before addressing the lesion 3, 2
  • Hypopigmentary skin changes can occur at intralesional steroid injection sites 3

Prevention Strategies

  • Regular eyelid hygiene for patients with blepharitis or meibomian gland dysfunction 1, 3, 2
  • Treat underlying skin conditions (rosacea, seborrheic dermatitis) 1, 3, 2
  • Avoid eye makeup during active inflammation 1, 3, 2

Special Populations

Pediatric Considerations

  • Children with chalazia should be evaluated for chronic blepharokeratoconjunctivitis, which may present with recurrent conjunctivitis, keratitis, and eyelid inflammation 1, 3, 2
  • Refer to ophthalmology if visual loss, moderate/severe pain, or severe/chronic redness present 1, 3

References

Guideline

Chalazion and Hordeolum Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Chalazion and Hordeolum Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chalazion Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Interventions for acute internal hordeolum.

The Cochrane database of systematic reviews, 2013

Research

Non-surgical interventions for acute internal hordeolum.

The Cochrane database of systematic reviews, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.